Telmisartan And Amlodipine Tablet
Product Images NDC 62332-186

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Telmisartan And Amlodipine (NDC 62332-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Telmiamlo Figure)

A set of four line graphs showing probabilities of achieving specific blood pressure targets at Week 8. Figures 1a and 1b display probabilities of achieving systolic blood pressure below 140 mmHg and 130 mmHg, respectively, across baseline systolic blood pressures. Figures 2a and 2b show probabilities of reaching diastolic blood pressures below 90 mmHg and 80 mmHg, respectively, versus baseline diastolic values. Treatment groups labeled include 40/10, 80/10, and Placebo.*

FDA Label Image

Structure (Telmiamlo Telmi)

Chemical structure diagram of the active ingredient depicted in the product, illustrating its molecular composition and connectivity.*

FDA Label Image

Structure (Telmiamlo Amlo)

Chemical structure diagram showing the molecular formula of Telmisartan and Amlodipine, the active ingredients in this oral tablet. The diagram displays bonded atoms and functional groups specific to these compounds.*

FDA Label Image

Tear (Telmiamlo Tear)

An instructional illustration showing a hand pressing on a tablet in a blister pack to release it. The image demonstrates the proper technique for removing tablets from their packaging, with an arrow indicating the direction to push the tablet out.*

FDA Label Image

Peal (Telmiamlo Peal)

An instructional illustration showing hands peeling back foil from a blister pack to remove a tablet, demonstrating how to access oral medication tablets from their packaging.*

FDA Label Image

30 Tablets (Telmiamlo 40 5 mg)

Label for Telmisartan and Amlodipine Tablets, USP 40 mg/5 mg, oral tablet form, manufactured by Alembic Pharmaceuticals Inc. The label indicates a package of 30 tablets, with storage instructions and a barcode. It also states that the product is prescription only and child-resistant packaging is used.*

FDA Label Image

30 Tablets (Telmiamlo 40 10 mg)

The label for Telmisartan and Amlodipine Tablets, USP, showing a dosage strength of 40 mg/10 mg. The packaging is for oral tablets in a count of 30, labeled Rx only. Manufactured by Alembic Pharmaceuticals Limited, India, and for Alembic Pharmaceuticals, Inc., USA. The label includes storage instructions and a barcode with GTIN 00362332185306.*

FDA Label Image

30 Tablets (Telmiamlo 80 5 mg)

Label for Telmisartan and Amlodipine Tablets USP, 80 mg/5 mg, oral tablets manufactured by Alembic Pharmaceuticals Limited. The label indicates a 30-tablet package and includes dosage strength, manufacturer details, storage instructions, and a barcode. The product is prescription only.*

FDA Label Image

30 Tablets (Telmiamlo 80 10 mg)

Label for Telmisartan and Amlodipine Tablets, USP 80 mg/10 mg oral tablets, containing 30 tablets per package. Manufactured by Alembic Pharmaceuticals Limited (Formulation Division) in Gujarat, India, for Alembic Pharmaceuticals, Inc., Bedminster, NJ, USA. The label includes storage instructions, barcode, NDC 62332-187-30, and states the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.